SAM
ELV icon

Sabadell Asset Management’s Elevance Health ELV Stock Holding History

Sabadell Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,121
Closed -$1.46M – 123
2022
Q2 		$1.46M Sell
3,121
-17,926
-85% -$8.87M 0.31% 72
2022
Q1 		$10.8M Buy
21,047
+160
+0.8% +$73.1K 1.87% 10
2021
Q4 		$9.33M Buy
20,887
+996
+5% +$419K 1.49% 17
2021
Q3 		$7.42M Buy
19,891
+8,981
+82% +$3.41M 1.28% 21
2021
Q2 		$4.17M Buy
+10,910
New +$4.17M 0.72% 46

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sabadell Asset Management's ELV Position: Q3 2022 in Review

Sabadell Asset Management sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 3,121 shares — an estimated $1.46M sold.

Sabadell Asset Management first reported a position in ELV in Q2 2021 and held it in 5 quarters. The position peaked at $10.8M in Q1 2022. 1,446 funds tracked by Wall St. Rank hold ELV as of Q3 2022.

  • Sabadell Asset Management reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
  • Sabadell Asset Management sold 3,121 Elevance Health shares in Q3 2022, an estimated $1.46M.
  • Sabadell Asset Management first reported a position in Elevance Health in Q2 2021 and held it in 5 quarters.
  • Sabadell Asset Management's Elevance Health position peaked at $10.8M in Q1 2022.
  • 1,446 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.

Based on Sabadell Asset Management's 13F filing for Q3 2022, filed 23 Jan 2024.